Home › Cancer (all types) › NCT04991922

BostonGene-Integrated Genomic Registry (BIGR)

BostonGene-Integrated Genomic Registry Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Suspected or confirmed malignancy
2. Planned comprehensive genomic (\> 100 genes) and/or molecular analysis; or genomic and/or molecular data available from prior sequencing
3. Baseline demographics and treatment information available
4. Willingness for future contact by BIRG study personnel to provide information regarding associated cancer outcomes and treatment.
5. Signed informed consent to participate in the study.
6. Living in the United States at the time of enrollment

Exclusion Criteria:

Life expectancy \< 3 months

About the study

The purpose of this project is to develop a comprehensive database of genomic, transcriptomic, molecular, and clinical characteristics of oncology patients to discover, define, and develop genomic and transcriptomic markers to improve future clinical outcomes across cancer types

Sponsor: BostonGene · Participants: 100,000 · Started: Jul 1, 2021

Contact the study team

• Nathan Fowler · Phone: +1-617-658-4545

Official record on ClinicalTrials.gov — NCT04991922

Locations in the U.S.

Conditions

• Cancer (all types)

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.